Mira Pharmaceuticals (MIRA) Shares Outstanding (Weighted Average) (2022 - 2025)

Mira Pharmaceuticals has disclosed Shares Outstanding (Weighted Average) across 4 years of filings, most recently posting $23.7 million for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $23.7 million, up 53.42% year-over-year; the trailing twelve-month figure through Dec 2025 was $23.7 million (up 53.42% YoY), and the FY2025 annual result was $23.7 million, up 53.42% from the prior year.
• Shares Outstanding (Weighted Average) came in at $23.7 million for Q4 2025 at Mira Pharmaceuticals, up from $19.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $23.7 million in Q4 2025 to a low of $63750.0 in Q2 2023.
• The 4-year median for Shares Outstanding (Weighted Average) is $14.8 million (2024), against an average of $14.2 million.
• Across the five-year window, Shares Outstanding (Weighted Average) plunged 99.51% in 2023 and jumped 23085.7% in 2024, its largest moves.
• Mira Pharmaceuticals' Shares Outstanding (Weighted Average) stood at $17.6 million in 2022, then decreased by 20.73% to $13.9 million in 2023, then increased by 10.91% to $15.4 million in 2024, then surged by 53.42% to $23.7 million in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $23.7 million (Q4 2025), $19.3 million (Q3 2025), and $17.0 million (Q2 2025), per Business Quant data.